Company profile
Iambic Therapeutics, Inc. insider acquisitions
Company CIK 0001997038 · Reported insider acquisitions and filing context.
IAM · Nasdaq
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | 10/14/2026Derivative · Currency not specified | 1 | Not applicable | 0 |
| Stock awardCode A | Common StockNon-derivative · Currency not specified | 5 | Not applicable | 0 |
| Stock awardCode A | Employee Stock Option (right to buy)Derivative · Currency not specified | 5 | Not applicable | 0 |
| Stock awardCode A | Stock Option (right to buy)Derivative · Currency not specified | 5 | Not applicable | 0 |
| ConversionCode C | Common StockNon-derivative · Currency not specified | 12 | Not applicable | 12 |
| PurchaseCode P | Common StockNon-derivative · Currency not specified | 1 | 11,500,000 | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
29 dated transactions · 8 of 16 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Vogelstein R Jacob | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Vogelstein R Jacob | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Vogelstein R Jacob | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Rachlin Evan Lockwood | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Rachlin Evan Lockwood | Purchase |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Rachlin Evan Lockwood | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Rachlin Evan Lockwood | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Petrocheilos George C · Catalio Nexus Fund III, LP · Catalio Capital Management, LP · Catalio Access Fund VIII, LLC · Catalio BH SPV, LLC | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Petrocheilos George C · Catalio Nexus Fund III, LP · Catalio Capital Management, LP · Catalio Access Fund VIII, LLC · Catalio BH SPV, LLC | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Petrocheilos George C · Catalio Nexus Fund III, LP · Catalio Capital Management, LP · Catalio Access Fund VIII, LLC · Catalio BH SPV, LLC | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | Secora Michael | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | RASTETTER WILLIAM H | Conversion |
| Oct 16, 2026 | Iambic Therapeutics, Inc.Common Stock | RASTETTER WILLIAM H | Conversion |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Employee Stock Option (right to buy) | Manby Frederick R | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Common Stock | Manby Frederick R | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Employee Stock Option (right to buy) | Olson Peter A | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Common Stock | Olson Peter A | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Stock Option (right to buy) | Vogelstein R Jacob | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Stock Option (right to buy) | Rachlin Evan Lockwood | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Employee Stock Option (right to buy) | Miller Thomas F. | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Common Stock | Miller Thomas F. | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Employee Stock Option (right to buy) | Josephson Neil | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Common Stock | Josephson Neil | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Employee Stock Option (right to buy) | Secora Michael | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Common Stock | Secora Michael | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Stock Option (right to buy) | Sharp Shalini | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.10/14/2026 | TAGLIAFERRI MARY | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Stock Option (right to buy) | EMSTER KURT VON | Stock award |
| Oct 14, 2026 | Iambic Therapeutics, Inc.Stock Option (right to buy) | RASTETTER WILLIAM H | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
IAM · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Vogelstein R JacobDirector | ConversionCommon StockNon-derivative security · Code C | 742,546 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Vogelstein R JacobDirector | ConversionCommon StockNon-derivative security · Code C | 1,458,290 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Vogelstein R JacobDirector | ConversionCommon StockNon-derivative security · Code C | 1,995,749 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Rachlin Evan LockwoodDirector | ConversionCommon StockNon-derivative security · Code C | 57,754 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Rachlin Evan LockwoodDirector | PurchaseCommon StockNon-derivative security · Code P | 718,750 | 16Value: 11,500,000Currency not specified | View ↗ |
| Trade: | Rachlin Evan LockwoodDirector | ConversionCommon StockNon-derivative security · Code C | 410,762 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Rachlin Evan LockwoodDirector | ConversionCommon StockNon-derivative security · Code C | 1,458,736 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Petrocheilos George C10% owner Catalio Nexus Fund III, LP10% owner Catalio Capital Management, LP10% owner Catalio Access Fund VIII, LLC10% owner Catalio BH SPV, LLC10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 742,546 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Petrocheilos George C10% owner Catalio Nexus Fund III, LP10% owner Catalio Capital Management, LP10% owner Catalio Access Fund VIII, LLC10% owner Catalio BH SPV, LLC10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 1,458,290 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Petrocheilos George C10% owner Catalio Nexus Fund III, LP10% owner Catalio Capital Management, LP10% owner Catalio Access Fund VIII, LLC10% owner Catalio BH SPV, LLC10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 1,995,749 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Secora MichaelCFO & Chief Corp Dev Ofcr | ConversionCommon StockNon-derivative security · Code C | 61,342 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | RASTETTER WILLIAM HDirector · Chairperson of the Board | ConversionCommon StockNon-derivative security · Code C | 8,341 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | RASTETTER WILLIAM HDirector · Chairperson of the Board | ConversionCommon StockNon-derivative security · Code C | 192,579 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Manby Frederick RChief Technology Officer · Director | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 793,200 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Manby Frederick RChief Technology Officer · Director | Stock awardCommon StockNon-derivative security · Code A | 132,200 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Olson Peter AChief Scientific Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 116,900 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Olson Peter AChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 19,500 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Vogelstein R JacobDirector · 10% owner | Stock awardStock Option (right to buy)Derivative security · Code A | 20,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Rachlin Evan LockwoodDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 20,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Miller Thomas F.Chief Executive Officer · Director | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 793,200 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Miller Thomas F.Chief Executive Officer · Director | Stock awardCommon StockNon-derivative security · Code A | 132,200 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Josephson NeilChief Medical Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 185,900 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Josephson NeilChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 31,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Secora MichaelCFO & Chief Corp Dev Ofcr | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 170,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Secora MichaelCFO & Chief Corp Dev Ofcr | Stock awardCommon StockNon-derivative security · Code A | 28,400 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Sharp ShaliniDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 20,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | TAGLIAFERRI MARYDirector | Stock award10/14/2026Derivative security · Code A | 20,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | EMSTER KURT VONDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 20,300 | 0Value: 0Currency not specified | View ↗ |
| Trade: | RASTETTER WILLIAM HDirector · Chairperson of the Board | Stock awardStock Option (right to buy)Derivative security · Code A | 40,600 | 0Value: 0Currency not specified | View ↗ |
29 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →